SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-101849
Filing Date
2023-09-19
Accepted
2023-09-19 12:08:43
Documents
7
Effectiveness Date
2023-09-19

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2326398d1_s8.htm S-8 55369
2 EXHIBIT 5.1 tm2326398d1_ex5-1.htm EX-5.1 11267
3 EXHIBIT 23.2 tm2326398d1_ex23-2.htm EX-23.2 3770
4 EXHIBIT 23.3 tm2326398d1_ex23-3.htm EX-23.3 2557
5 EX-FILING FEES tm2326398d1_ex-filingfees.htm EX-FILING FEES 15594
6 GRAPHIC tm2326398d1_ex23-2img001.jpg GRAPHIC 5922
7 GRAPHIC tm2326398d1_ex23-2img002.jpg GRAPHIC 8826
  Complete submission text file 0001104659-23-101849.txt   110191
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274575 | Film No.: 231262981
SIC: 2834 Pharmaceutical Preparations